Cargando…

Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma

BACKGROUND: Tight junctions (TJs) are mainly composed of claudins, occludin, and tight junction adhesion molecules (JAM). The invasive and metastatic phenotype of highly invasive cancer cells has been related to abnormal structure and function of TJs, and with expression of activated matrix metallop...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liping, Jin, Xiangshu, Lin, Dongjing, Liu, Zhijing, Zhang, Xiaowei, Lu, Yan, Liu, Yuanyuan, Wang, Min, Yang, Minlan, Li, Jiuxia, Quan, Chengshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866569/
https://www.ncbi.nlm.nih.gov/pubmed/24245968
http://dx.doi.org/10.1186/1746-1596-8-190
_version_ 1782296181664120832
author Wang, Liping
Jin, Xiangshu
Lin, Dongjing
Liu, Zhijing
Zhang, Xiaowei
Lu, Yan
Liu, Yuanyuan
Wang, Min
Yang, Minlan
Li, Jiuxia
Quan, Chengshi
author_facet Wang, Liping
Jin, Xiangshu
Lin, Dongjing
Liu, Zhijing
Zhang, Xiaowei
Lu, Yan
Liu, Yuanyuan
Wang, Min
Yang, Minlan
Li, Jiuxia
Quan, Chengshi
author_sort Wang, Liping
collection PubMed
description BACKGROUND: Tight junctions (TJs) are mainly composed of claudins, occludin, and tight junction adhesion molecules (JAM). The invasive and metastatic phenotype of highly invasive cancer cells has been related to abnormal structure and function of TJs, and with expression of activated matrix metalloproteinases (MMPs). The relevance of these mechanisms responsible for the invasion and metastasis of ovarian carcinoma is unclear. Similarly, it is not known if the expression of claudin-6, occludin and MMP2 is related with the clinical properties of these tumors. METHODS: Expression of claudin-6, occludin, and MMP2 was detected in samples of human ovarian cancer tissues by immunohistochemistry and correlated with the clinical properties of the tumors. RESULTS: The positive expression rates of claudin-6 and MMP-2 were higher in ovarian papillary serous carcinomas than n ovarian serous adenomas (P < 0.05). There were no differences in the expression of occludin (P > 0.05). The expression of claudin-6 and occludin in ovarian cancer was not correlated with patient age, pathological grade, clinical stage, and metastasis (P > 0.05). MMP-2 expression was enhanced with increased clinical stage and metastasis (P < 0.05), but was unrelated to patient age or tumor grade (P > 0.05). There were no apparent correlations between expression of claudin-6, occludin and MMP-2 in ovarian cancer tissue (P > 0.05). CONCLUSIONS: Our data suggest, for the first time, that the claudin-6 and MMP-2 are up-regulated in ovarian papillary serous carcinomas, MMP-2 expression was enhanced with increased clinical stage and metastasis. Claudin-6 and MMP-2 may play a positive role in the invasion and metastasis of ovarian cancer. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1775628454106511.
format Online
Article
Text
id pubmed-3866569
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38665692013-12-19 Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma Wang, Liping Jin, Xiangshu Lin, Dongjing Liu, Zhijing Zhang, Xiaowei Lu, Yan Liu, Yuanyuan Wang, Min Yang, Minlan Li, Jiuxia Quan, Chengshi Diagn Pathol Research BACKGROUND: Tight junctions (TJs) are mainly composed of claudins, occludin, and tight junction adhesion molecules (JAM). The invasive and metastatic phenotype of highly invasive cancer cells has been related to abnormal structure and function of TJs, and with expression of activated matrix metalloproteinases (MMPs). The relevance of these mechanisms responsible for the invasion and metastasis of ovarian carcinoma is unclear. Similarly, it is not known if the expression of claudin-6, occludin and MMP2 is related with the clinical properties of these tumors. METHODS: Expression of claudin-6, occludin, and MMP2 was detected in samples of human ovarian cancer tissues by immunohistochemistry and correlated with the clinical properties of the tumors. RESULTS: The positive expression rates of claudin-6 and MMP-2 were higher in ovarian papillary serous carcinomas than n ovarian serous adenomas (P < 0.05). There were no differences in the expression of occludin (P > 0.05). The expression of claudin-6 and occludin in ovarian cancer was not correlated with patient age, pathological grade, clinical stage, and metastasis (P > 0.05). MMP-2 expression was enhanced with increased clinical stage and metastasis (P < 0.05), but was unrelated to patient age or tumor grade (P > 0.05). There were no apparent correlations between expression of claudin-6, occludin and MMP-2 in ovarian cancer tissue (P > 0.05). CONCLUSIONS: Our data suggest, for the first time, that the claudin-6 and MMP-2 are up-regulated in ovarian papillary serous carcinomas, MMP-2 expression was enhanced with increased clinical stage and metastasis. Claudin-6 and MMP-2 may play a positive role in the invasion and metastasis of ovarian cancer. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1775628454106511. BioMed Central 2013-11-19 /pmc/articles/PMC3866569/ /pubmed/24245968 http://dx.doi.org/10.1186/1746-1596-8-190 Text en Copyright © 2013 Wang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wang, Liping
Jin, Xiangshu
Lin, Dongjing
Liu, Zhijing
Zhang, Xiaowei
Lu, Yan
Liu, Yuanyuan
Wang, Min
Yang, Minlan
Li, Jiuxia
Quan, Chengshi
Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma
title Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma
title_full Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma
title_fullStr Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma
title_full_unstemmed Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma
title_short Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma
title_sort clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866569/
https://www.ncbi.nlm.nih.gov/pubmed/24245968
http://dx.doi.org/10.1186/1746-1596-8-190
work_keys_str_mv AT wangliping clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma
AT jinxiangshu clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma
AT lindongjing clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma
AT liuzhijing clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma
AT zhangxiaowei clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma
AT luyan clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma
AT liuyuanyuan clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma
AT wangmin clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma
AT yangminlan clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma
AT lijiuxia clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma
AT quanchengshi clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma